InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: NASDAQ2020 post# 289466

Thursday, 05/17/2018 8:45:09 AM

Thursday, May 17, 2018 8:45:09 AM

Post# of 402517
Nope.











The article you cite was written prior to the Troxyca AdComm, based on the FDA Briefing Document for the AdComm. The FDA advisors did vote against the oral abuse label, but when Troxyca received approval from FDA a few months later it was with all 3 ADF labels: IV, snorting, and oral abuse by chewing. So, this article is not the reason Troxyca never went to market.











Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News